Ameritas Investment Partners’s Definium Therapeutics DFTX Stock Holding History

Ameritas Investment Partners’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$144K	Hold	7,641	–	–	﹤0.01%	1458
2025 Q4	$102K	Buy	7,641 +588	+8%	+$7.28K	﹤0.01%	1683
2025 Q3	$83.2K	Hold	7,053	–	–	﹤0.01%	1797
2025 Q2	$45.8K	Hold	7,053	–	–	﹤0.01%	2242
2025 Q1	$41.3K	Hold	7,053	–	–	﹤0.01%	2219
2024 Q4	$49.1K	Hold	7,053	–	–	﹤0.01%	2194
2024 Q3	$40.1K	Hold	7,053	–	–	﹤0.01%	2320
2024 Q2	$50.9K	Buy	+7,053	New	+$61.7K	﹤0.01%	2137
2022 Q2	–	Sell	-1,684	Closed	-$28K	–	3172
2022 Q1	$28K	Hold	1,684	–	–	﹤0.01%	2401
2021 Q4	$35K	Hold	1,684	–	–	﹤0.01%	2351
2021 Q3	$59K	Hold	1,684	–	–	﹤0.01%	2047
2021 Q2	$87K	Buy	+1,684	New	+$88.4K	﹤0.01%	1816

Other funds holding DFTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameritas Investment Partners's DFTX Position: Q1 2026 in Review

Ameritas Investment Partners held its Definium Therapeutics (DFTX) position steady in Q1 2026 at 7,641 shares worth $144K. The position accounts for ﹤0.01% of the portfolio, ranked #1458.

Ameritas Investment Partners first reported a position in DFTX in Q2 2021 and has held it in 12 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

Ameritas Investment Partners held 7,641 shares of Definium Therapeutics worth $144K as of Q1 2026.
Ameritas Investment Partners left its Definium Therapeutics share count unchanged in Q1 2026.
Definium Therapeutics made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #1458 holding.
Ameritas Investment Partners first reported a position in Definium Therapeutics in Q2 2021 and has held it in 12 quarters since.
247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.